Tetra Therapeutics (formerly known as Tetra Discovery Partners) is a pharmaceutical drug development company providing medicines for Alzheimer's Disease, traumatic brain injury, and schizophrenia. It designs drugs to treat memory loss and cognitive impairment by improving how the brain processes and stores information.
|HQ||East Grand Rapids, US||Map|
|Employees (est.) (May 2020)||11|
Tetra Therapeutics total Funding
Tetra Therapeutics latest funding size
Time since last funding
|4 years ago|
Tetra Therapeutics investors
|Dolby Family Ventures, Apjohn ventures, Grand Angels, Biosciences Research and Commercialization Center (BRCC), Michigan Emerging Technology Fund, Michigan, Muskegon Angels, J &J Investments|
Tetra Therapeutics has 91 Twitter Followers. The number of followers has increased 0.6% month over month
When was Tetra Therapeutics founded?
Tetra Therapeutics was founded in 2010.
Who are Tetra Therapeutics key executives?
Tetra Therapeutics's key executives are Mark E. Gurney, Joseph Collard and Chad A. Coberly.
How many employees does Tetra Therapeutics have?
Tetra Therapeutics has 11 employees.
Who are Tetra Therapeutics competitors?
Competitors of Tetra Therapeutics include Quench Medical, Scynexis and Sciwind.
Where is Tetra Therapeutics headquarters?
Tetra Therapeutics headquarters is located at 2220 Wealthy St SE, East Grand Rapids.
Where are Tetra Therapeutics offices?
Tetra Therapeutics has an office in East Grand Rapids.
How many offices does Tetra Therapeutics have?
Tetra Therapeutics has 1 office.
Receive alerts for 300+ data fields across thousands of companies